David MacDonald

Director Técnico/Científico/I+D en XORTX THERAPEUTICS INC. .

Health Technology

Consumer Services

Miscellaneous

Cargos activos de David MacDonald

Empresas	Cargo	Inicio	Fin
XORTX THERAPEUTICS INC.	Director Técnico/Científico/I+D	20/01/2022	-

Historial de carrera de David MacDonald

Antiguos cargos conocidos de David MacDonald.

Empresas	Cargo	Inicio	Fin
Immunoflex Therapeutics, Inc.	Director Técnico/Científico/I+D	01/01/2020	01/01/2021
Biovail Contract Research Division	Corporate Officer/Principal	-	-
Hemosol Corp. /Old/ Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin.	Corporate Officer/Principal	-	-
Syntex, Inc.	Corporate Officer/Principal	-	-
MSI Methylation Sciences, Inc. MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada.	Director Técnico/Científico/I+D	01/01/2008	01/03/2017
	Presidente	01/03/2017	-
Active Pass Pharmaceuticals, Inc. Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada.	Director Ejecutivo	01/06/2004	-
	Presidente	01/06/2004	-

Formación de David MacDonald.

University of Alberta

Doctorate Degree

Estadísticas

Internacional

Canadá

Operativa

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	3
President	2

Sectorial

Health Technology	5
Consumer Services	2
Miscellaneous	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas relacionadas

Empresas cotizadas	1
XORTX THERAPEUTICS INC.	Health Technology

Empresas privadas	6
MSI Methylation Sciences, Inc. MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada.	Health Technology
Hemosol Corp. /Old/ Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin.	Health Technology
Active Pass Pharmaceuticals, Inc. Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada.	Health Technology
Syntex, Inc.	Miscellaneous
Biovail Contract Research Division	Commercial Services
Immunoflex Therapeutics, Inc.

Ver las conexiones de la empresa